Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theresa A Zesiewicz

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Nature Reviews. Neurology|December 27, 2011
Parkinson disease: the controversy of levodopa toxicity in Parkinson diseaseTheresa A Zesiewicz
Continuum (Minneapolis, Minn.)|July 30, 2019
Parkinson DiseaseTheresa A Zesiewicz
Clinical Neuropharmacology|September 1, 2007
Low-dose topiramate (topamax) in the treatment of essential tremorTheresa A Zesiewicz
Continuum (Minneapolis, Minn.)|August 1, 2025
AtaxiaTheresa A Zesiewicz
Handbook of Clinical Neurology|April 19, 2011
Drug-induced hyperkinetic movement disorders by nonneuroleptic agentsTheresa A Zesiewicz, Kelly L Sullivan
Expert Review of Neurotherapeutics|November 19, 2013
Effects of rotigotine transdermal system on non-motor symptoms in Parkinson's disease: an overviewTheresa A Zesiewicz, Pablo Martinez-Martin
Current Psychiatry Reports|January 30, 2002
Depression in Parkinson's diseaseTheresa A Zesiewicz, Robert A Hauser
The Neurologist|May 15, 2007
Advances in the pharmacologic management of early Parkinson diseaseRobert A Hauser, Theresa A Zesiewicz
CNS Drugs|May 31, 2003
Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?Theresa A Zesiewicz, Robert A Hauser
Clinical Neuropharmacology|December 4, 2008
Treatment of ataxia and imbalance with varenicline (chantix): report of 2 patients with spinocerebellar ataxia (types 3 and 14)Theresa A Zesiewicz, Kelly L Sullivan
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Nature Reviews. Neurology|December 27, 2011
Parkinson disease: the controversy of levodopa toxicity in Parkinson diseaseTheresa A Zesiewicz
Continuum (Minneapolis, Minn.)|July 30, 2019
Parkinson DiseaseTheresa A Zesiewicz
Clinical Neuropharmacology|September 1, 2007
Low-dose topiramate (topamax) in the treatment of essential tremorTheresa A Zesiewicz
Continuum (Minneapolis, Minn.)|August 1, 2025
AtaxiaTheresa A Zesiewicz
Handbook of Clinical Neurology|April 19, 2011
Drug-induced hyperkinetic movement disorders by nonneuroleptic agentsTheresa A Zesiewicz, Kelly L Sullivan
Expert Review of Neurotherapeutics|November 19, 2013
Effects of rotigotine transdermal system on non-motor symptoms in Parkinson's disease: an overviewTheresa A Zesiewicz, Pablo Martinez-Martin
Current Psychiatry Reports|January 30, 2002
Depression in Parkinson's diseaseTheresa A Zesiewicz, Robert A Hauser
The Neurologist|May 15, 2007
Advances in the pharmacologic management of early Parkinson diseaseRobert A Hauser, Theresa A Zesiewicz
CNS Drugs|May 31, 2003
Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?Theresa A Zesiewicz, Robert A Hauser
Clinical Neuropharmacology|December 4, 2008
Treatment of ataxia and imbalance with varenicline (chantix): report of 2 patients with spinocerebellar ataxia (types 3 and 14)Theresa A Zesiewicz, Kelly L Sullivan
Pageof 10